Distal Pankreatektomi Sonrası Pankreatik Fistül Gelişimini Tahmin Etmede İnflamatuar İndekslerin Rolü

Year 2025, Volume: 22 Issue: 2, 255 - 259, 27.06.2025

Gökay Çetinkaya , Ahmet Cihangir Emral , Mustafa Kerem

https://doi.org/10.35440/hutfd.1635628

Abstract

Amaç: İnflamatuar belirteçlerin, distal pankreatektomi sonrası pankreatik fistül gelişimini tahmin etmedeki önemi, bu konuda yapılan çalışmalarla yeterince derinlemesine incelenmemiştir. Bu çalış-ma, distal pankreatektomi yapılan hastalarda postoperatif inflamatuar indekslerin, özellikle SII (siste-mik immün inflamasyon indeksi), NLR (nötrofil-lenfosit oranı) ve PLR (trombosit-lenfosit oranı), pank-reatik fistül gelişimi ile ilişkisini değerlendirmeyi amaçlamaktadır.
Materyal ve Metod: Bu retrospektif çalışmada, Ocak 2020 ile Aralık 2023 arasında pankreatik kanser nedeniyle distal pankreatektomi uygulanan hastalar analiz edilmiştir. İstatistiksel analizler, pankreatik fistül (B ve C dereceleri) gelişen hastaların, üçüncü postoperatif günde elde edilen laboratuvar sonuç-larına dayalı olarak hesaplanan SII, NLR ve PLR verileri retrospektif olarak incelenerek yapılmıştır.
Bulgular: Çalışmaya, belirlenen kriterlere uyan 72 hasta dahil edildi. Bu hastaların 25'inde (% 34.7) pankreatik fistül gözlemlendi. Bu çalışmada, BMI ve yumuşak pankreatik doku pankreatik fistül gelişimi için istatistiksel olarak anlamlı risk faktörleri olarak bulundu (her ikisi için p=0.02). Postoperatif üçün-cü günde ölçülen SII ve NLR, pankreatik fistül gelişiminin istatistiksel olarak anlamlı prediktörleri olurken, postoperatif PLR’nin pankreatik fistül gelişimini tahmin etmede istatiksel anlamlı sonuç vermediği görüldü. SII’nin pankreatik fistül gelişiminin tahmin edilmesinde NLR'den daha güçlü bir prediktör olduğu görüldü.
Sonuç: Bu çalışma, inflamasyonla ilişkili indeksler olan SII ve NLR'deki artışın, distal pankreatektomi sonrası pankreatik fistül gelişiminin tahmin edilmesinde etkili bir yöntem olduğunu göstermektedir. Buna karşılık, PLR'nin pankreatik fistül gelişimini tahmin etmede etkili olmadığı görüldü.

Keywords

distal pankreatektomi , pankreatik fistül , SII , NLR , PLR

The Role of Inflammatory Indices in Predicting Pancreatic Fistula After Distal Pancreatectomy

Abstract

Background: The significance of inflammatory markers in forecasting pancreatic fistula development has not been thoroughly investigated in patients who have undergone distal pancreatectomy. This study seeks to assess the predictive value of postoperative inflammatory indices, particularly SII (systemic immune inflammation index), NLR (neutrophil-to-lymphocyte ratio) and PLR (platelet-to-lymphocyte ratio), concerning the onset of pancreatic fistula in these patients.
Materials and Methods: This retrospective study analyzed patients who underwent distal pancreatec-tomy for pancreatic cancer between January 2020 and December 2023. Statistical analyses were performed by retrospectively examining the data obtained from the prospectively filled clinical notes of patients who developed pancreatic fistula (Grade B and C) using the SII, NLR and PLR calculated based on the laboratory results obtained on the third postoperative day.
Results: The study included 72 patients who fulfilled the established criteria. Pancreatic fistulas were observed in 25 (34.7%) of the patients. In this study, BMI and soft pancreatic tissue were statistically significant risk factors for pancreatic fistula development (p=0.02 for both). SII and NLR from the third postoperative day were statistically significant predictors of pancreatic fistula development, while postoperative PLR did not provide statistically significant results. SII was a more significant predictor of pancreatic fistula than NLR.
Conclusions: This study conveys that monitoring the increase in SII and NLR, which are inflammation-related indices, is an effective method for predicting the development of pancreatic fistula after distal pancreatectomy, whereas PLR is not effective in predicting the development of pancreatic fistula.

Keywords

distal pancreatectomy , pancreatic fistula , SII , NLR , PLR

References

• 1. Oneil Machado N. Pancreatic fistula after pancreatectomy: definitions, risk factors, preventive measures, and manage-ment. International journal of surgical oncology. 2012;2012(1):602478.
• 2. Ecker BL, McMillan MT, Allegrini V, Bassi C, Beane JD, Beck-man RM, et al. Risk Factors and Mitigation Strategies for Pan-creatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group. Ann Surg. 2019;269(1):143-9. doi: 10.1097/sla.0000000000002491. PubMed PMID: 28857813.
• 3. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancre-atic fistula: 11 Years After. Surgery. 2017;161(3):584-91. Epub 20161228. doi: 10.1016/j.surg.2016.11.014. PubMed PMID: 28040257.
• 4. Goh BK, Tan YM, Chung YF, Cheow PC, Ong HS, Chan WH, et al. Critical appraisal of 232 consecutive distal pancreatecto-mies with emphasis on risk factors, outcome, and manage-ment of the postoperative pancreatic fistula: a 21-year expe-rience at a single institution. Arch Surg. 2008;143(10):956-65. doi: 10.1001/archsurg.143.10.956. PubMed PMID: 18936374.
• 5. Knaebel HP, Diener MK, Wente MN, Büchler MW, Seiler CM. Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg. 2005;92(5):539-46. doi: 10.1002/bjs.5000. PubMed PMID: 15852419.
• 6. Jiao Y, Zhang X, Liu M, Sun Y, Ma Z, Gu X, et al. Systemic immune-inflammation index within the first postoperative hour as a predictor of severe postoperative complications in upper abdominal surgery: a retrospective single-center study. BMC Gastroenterol. 2022;22(1):403. Epub 20220827. doi: 10.1186/s12876-022-02482-9. PubMed PMID: 36030214; PubMed Central PMCID: PMC9419130.
• 7. Ma M, Li G, Zhou B, Li K, Wu Z, Kong L, et al. Comprehensive analysis of the association between inflammation indexes and complications in patients undergoing pancreaticoduodenec-tomy. Front Immunol. 2023;14:1303283. Epub 20231123. doi: 10.3389/fimmu.2023.1303283. PubMed PMID: 38077320; PubMed Central PMCID: PMC10702568.
• 8. Schlanger D, Popa C, Pașca S, Seicean A, Al Hajjar N. The role of systemic immuno-inflammatory factors in resectable pan-creatic adenocarcinoma: a cohort retrospective study. World J Surg Oncol. 2022;20(1):144. Epub 20220506. doi: 10.1186/s12957-022-02606-1. PubMed PMID: 35513845; PubMed Central PMCID: PMC9074307.
• 9. Uluç K, Turan H. Prognostic Value of Systemic Immune-Inflammation Index (SII), Platelet-Lymphocyte Ratio (PLR) and Neutrophil-Lymphocyte Ratio (NLR) in Predicting Mortality in Pneumosepsis Patients in Intensive Care Unit. Harran Üniver-sitesi Tıp Fakültesi Dergisi. 2024;21(3):490-5.
• 10. Islam MM, Satici MO, Eroglu SE. Unraveling the clinical signifi-cance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review. Turk J Emerg Med. 2024;24(1):8-19. Epub 20240108. doi: 10.4103/tjem.tjem_198_23. PubMed PMID: 38343523; PubMed Central PMCID: PMC10852137.
• 11. Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14. PubMed PMID: 11723675.
• 12. Menges T, Engel J, Welters I, Wagner RM, Little S, Ruwoldt R, et al. Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med. 1999;27(4):733-40. doi: 10.1097/00003246-199904000-00026. PubMed PMID: 10321662.
• 13. Smith RA, Bosonnet L, Ghaneh P, Sutton R, Evans J, Healey P, et al. The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery. 2008;143(5):658-66. Epub 20080328. doi: 10.1016/j.surg.2007.12.014. PubMed PMID: 18436014.
• 14. Qi XY, Tan F, Liu MX, Xu K, Gao P, Yao ZD, et al. Serum and peritoneal biomarkers for the early prediction of symptomat-ic anastomotic leakage in patients following laparoscopic low anterior resection: A single-center prospective cohort study. Cancer Rep (Hoboken). 2023;6(4):e1781. Epub 20230131. doi: 10.1002/cnr2.1781. PubMed PMID: 36718787; PubMed Central PMCID: PMC10075299.
• 15. Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Ogata Y. Validation and clinical usefulness of pre- and post-operative systemic inflammatory parameters as prognostic markers in patients with potentially resectable pancreatic cancer. Pancreatology. 2020;20(2):239-46. Epub 20191214. doi: 10.1016/j.pan.2019.12.004. PubMed PMID: 31862230.
• 16. Liu CQ, Yu ZB, Gan JX, Mei TM. Preoperative blood markers and intra-abdominal infection after colorectal cancer resec-tion. World J Gastrointest Surg. 2024;16(2):451-62. doi: 10.4240/wjgs.v16.i2.451. PubMed PMID: 38463368; PubMed Central PMCID: PMC10921215.
• 17. Kohl BA, Deutschman CS. The inflammatory response to sur-gery and trauma. Curr Opin Crit Care. 2006;12(4):325-32. doi: 10.1097/01.ccx.0000235210.85073.fc. PubMed PMID: 16810043.
• 18. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg. 2006;141(11):1132-40. doi: 10.1001/archsurg.141.11.1132. PubMed PMID: 17116807.